Osoyoos Cannabis provides additional details on its previously announced acquisition.

Psychedelic drug R&D is ramping up rapidly. The number of past and current clinical studies on these substances will surprise you.

The Psychedelics Revolution. One part changing social attitudes. One part medical necessity. One part hard economics.

Novamind Ventures is preparing to go public via amalgamation with unlisted public company Hinterland Metals.

Cybin Corp is partnering with IntelGenx Corp to produce a new delivery system for pharmaceutical-grade psilocybin.

Mydecine Innovations Group has added one of the world’s pre-eminent biotech scientists to its Scientific Advisory Board.

Mydecine’s new Scientific Advisor holds over 150 U.S. and international patents and will oversee Mydecine’s mycology lab.

Three private companies are merging to create a new entity in the psychedelics space.

Hollister Biosciences announces a private placement for CAD$1.5 million, expected to close by July 12, 2020.

Entheon Biomedical announces a thee-cornered amalgamation with MPV Exploration and concurrent financing.